ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth
Crossref DOI link: https://doi.org/10.1158/1535-7163.MCT-17-0848
Published Online: 2018-07-01
Published Print: 2018-07-01
Update policy: https://doi.org/10.1158/crossmark_policy
Ward, George A.
Lewis, Edward J.
Ahn, Jong Sook
Johnson, Christopher N.
Lyons, John F.
Martins, Vanessa
Munck, Joanne M.
Rich, Sharna J.
Smyth, Tomoko
Thompson, Neil T.
Williams, Pamela A.
Wilsher, Nicola E.
Wallis, Nicola G.
Chessari, Gianni
